Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

Clinical trial NCT00596830 · TERMINATED

Trial details

NCT number: NCT00596830
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell Carcinoma, Adenosquamous Carcinoma, Large Cell Carcinoma, Non-Small-Cell Lung

Start date: 2008-04-01
Primary completion: 2011-03-01
Enrollment: 681

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.